New Lung Tumor Scoring System

New Lung Tumor Scoring System

A new pathologic scoring system — that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments such as immunotherapy or chemotherapy — can be used to predict survival. This new research is led by investigators at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University.

 READ HERE
SEE ALL NEWS
Recent Posts
Podcast: Colorectal Cancer Why age matters when it comes to cancer Liquid Biopsy Predicts Response in Patients with Advanced Lung Cancer Experimental Drug Combination Shows Promise Against Hard-to-Treat Tumors What are the risk factors for Pancreatic Cancer? Prostate Cancer: Advancements in Screenings 5 Healthy Habits That Help You During Lung Cancer Treatment Six Mammogram Myths Active Care Model Predicts Disease Course for Prostate Cancers